1-2 of 2
Hyeon Seok Eom, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicenter Phase II Trial of Etoposide, Methylprednisolone, High-Dose Cytarabine, and Oxaliplatin (ESHAOx) for Patients with Refractory/Relapsed Aggressive Non-Hodgkin’s Lymphoma.

Sun Jin Sym, MD, Hye Jin Kang, M.D., Seung-Hyun Nam, M.D., Hoyoung Kim, M.D., Seok Jin Kim, M.D., Hyeon Seok Eom, M.D., Won Seog Kim, M.D., Cheolwon Suh, M.D.
Journal: Blood
Blood (2007) 110 (11): 3446.
https://doi.org/10.1182/blood.V110.11.3446.3446
Published: 2007
Journal Articles

Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (VELCADE®, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with VELCADE for Newly Diagnosed Multiple Myeloma: Interim Results of Phase II Trial.

Sung-Soo Yoon, MD, Hye Jin Kim, M.D., Dong Soon Lee, M.D., Hyeon Seok Eom, M.D., Jun Ho Jang, M.D., Ju Seup Chung, M.D., Hye Jin Kang, M.D., Cheol Soo Kim, M.D., Kihyun Kim, M.D., Jae Hoon Lee, M.D., Sang Jae Lee, M.D., Yu Hong Min, M.D., Chu Myong Seong, M.D., Sang Kyun Sohn, M.D., Cheolwon Suh, M.D., Jong Ho Won, M.D.
Journal: Blood
Blood (2007) 110 (11): 952.
https://doi.org/10.1182/blood.V110.11.952.952
Published: 2007